"Not all GLP-1s are the same." Retatrutide, the 'King Kong' drug to mimic bariatric surgery Eli Lilly isn't pivoting away from weekly weight loss injections entirely. It's also working on another ...

An experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight. Randomized controlled trials (RCTs) assessed the efficacy and safety of ...

Retatrutide is a synthetic peptide, which research indicates functions as a triple agonist for type 2 diabetes and weight loss. Peptides, small chains of amino acids, have been hypothesized to ...

The new experimental weight loss drug, Retatrutide, is showing promising results. According to a study in the Annals of Internal Medicine, Retatrutide may help obese adults shed more pounds than ...

placebo across 26 randomized studies. Retatrutide conferred the greatest weight reduction among all GLP-1s. A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight ...

Can Lilly immunize retatrutide from compounded copies? Will the district court second guess – much less overturn – FDA’s decision to regulate this GLP-1 as a drug? Although perhaps a bit ...